Novo Nordisk's chief financial officer said: After Wegovy diet pills were marketed in the US, the UK and the UAE, patients mainly purchased the drugs at their own expense, and 90% of prescriptions were made at their own expense.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.